Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James A. Johnson currently holds 28,000 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James A. Johnson has been a net seller of ATHA stock. They have purchased $12.0K and sold $1.0M worth of shares.
James A. Johnson's most recent insider trade was on Jun 23, 2026, when they sold 28,000 shares at $0.00 per share.
James A. Johnson serves as Executive at Athira Pharma, Inc. (ATHA). They have executed 31 insider transactions totaling $1.0M over their tenure at the company.
James A. Johnson holds the position of Executive at Athira Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James A. Johnson has shown a selling trading pattern, with $12.0K in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James A. Johnson was on Oct 8, 2010, when they sold $253.7K worth of ZGEN shares. This transaction involved 26,019 shares at $9.75 per share.
James A. Johnson currently owns 28,000 shares of Athira Pharma, Inc. (ATHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James A. Johnson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James A. Johnson has 31 Form 4 filings on record as an insider at Athira Pharma, Inc..
Set alerts for James A. Johnson and 40,000+ other insiders.